|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/06 | (2013.01) |
| A61K 31/395 | (2006.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61K 31/502 | (2006.01) | ||
| A61K 31/55 | (2013.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61K 38/05 | (2013.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61K 31/407 | (2013.01) | ||
| A61K 31/58 | (2013.01) | ||
| A61K 31/573 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61K 31/69 | (2013.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 31/427 | (2013.01) | ||
| A61K 31/502 | (2013.01) |
| (11) | Patento numeris | 3148529 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15715192.9 |
| Europos patento paraiškos padavimo data | 2015-03-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-10-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/056667 |
| Data | 2015-03-26 |
| (87) | Numeris | WO 2015/180865 |
| Data | 2015-12-03 |
| (30) | Numeris | Data | Šalis |
| 201409471 | 2014-05-28 | GB |
| (72) |
MEHRLING, Thomas , CH
FESTUCCIA, Claudio , IT
|
| (73) |
Euro-Celtique S.A. ,
1, rue Jean Piret, 2350 Luxembourg,
LU
|
| (54) | COMPOUNDS FOR TREATING BRAIN CANCER |
| COMPOUNDS FOR TREATING BRAIN CANCER |